medlr news Suven Pharmaceuticals Transforms into Cohance Lifesciences to Drive Global CDMO Innovation Suven Pharmaceuticals evolves into Cohance Lifesciences, embracing a future-ready identity focused on innovation and global CDMO excellence.
medlr news NCLT Approves Merger of Cohance Lifesciences with Suven Pharmaceuticals Suven Pharmaceuticals merges with Cohance Lifesciences, forming a cutting-edge CDMO platform specializing in ADCs, oligonucleotides, and small molecules.
